IN2014CN00747A - - Google Patents

Info

Publication number
IN2014CN00747A
IN2014CN00747A IN747CHN2014A IN2014CN00747A IN 2014CN00747 A IN2014CN00747 A IN 2014CN00747A IN 747CHN2014 A IN747CHN2014 A IN 747CHN2014A IN 2014CN00747 A IN2014CN00747 A IN 2014CN00747A
Authority
IN
India
Prior art keywords
haa
atherosclerosis
prophylactic
mammals
special
Prior art date
Application number
Inventor
Göran K Hansson
Daniel Ketelhuth
Original Assignee
Göran K Hansson
Daniel Ketelhuth
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Göran K Hansson, Daniel Ketelhuth filed Critical Göran K Hansson
Publication of IN2014CN00747A publication Critical patent/IN2014CN00747A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Abstract

The present invention relates to the use of a tryptophan metabolite 3 hydroxyanthranilic acid (3 HAA)or a functional analogue thereof for prophylactic and/or therapeutic treatment of mammals in special humans against hyperlipidemia and its cardiovascular complications i.e atheroma formation myocardial infarction and heart failure ischemic stroke and transient ischemic attacks renal impairment aortic aneurysms and critical limb ischemia caused by atherosclerosis.
IN747CHN2014 2011-07-29 2012-07-13 IN2014CN00747A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE1150728 2011-07-29
PCT/SE2012/050835 WO2013019156A1 (en) 2011-07-29 2012-07-13 3-hydroxyanthranilic acid (3-haa) therapy for prevention and treatment of hyperlipidemia and its cardiovascular complications

Publications (1)

Publication Number Publication Date
IN2014CN00747A true IN2014CN00747A (en) 2015-04-03

Family

ID=47629522

Family Applications (1)

Application Number Title Priority Date Filing Date
IN747CHN2014 IN2014CN00747A (en) 2011-07-29 2012-07-13

Country Status (13)

Country Link
US (1) US20140296567A1 (en)
EP (1) EP2736505B1 (en)
JP (1) JP2014523925A (en)
KR (1) KR20140060288A (en)
CN (1) CN103841967A (en)
AU (1) AU2012290734A1 (en)
CA (1) CA2843401A1 (en)
EA (1) EA023954B1 (en)
IL (1) IL230694A0 (en)
IN (1) IN2014CN00747A (en)
MX (1) MX343138B (en)
WO (1) WO2013019156A1 (en)
ZA (1) ZA201400695B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11376248B2 (en) 2017-06-30 2022-07-05 Georgia State University Research Foundation, Inc. Treatment of aneurysms
WO2019006384A1 (en) * 2017-06-30 2019-01-03 Georgia State University Research Foundation, Inc. Treatment of aneurysms
WO2019147182A1 (en) * 2018-01-29 2019-08-01 Medscienta Ab Antiatherosclerotic agents

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2652332A (en) * 1951-07-19 1953-09-15 Harold S Olcott Stabilization of lipoidal substances
WO2006122353A1 (en) * 2005-05-16 2006-11-23 Angiogen Pharmaceuticals Pty. Ltd. Methods and compositions for the treatment of pain
US8486953B2 (en) * 2008-08-26 2013-07-16 Boehringer Ingelheim International Gmbh Thienopyrimidines for pharmaceutical compositions
WO2011065389A1 (en) * 2009-11-27 2011-06-03 独立行政法人科学技術振興機構 Method for screening of therapeutic agent for hyperlipemia
CN102762209A (en) * 2009-12-30 2012-10-31 有限公司公元前世界医药 Pharmaceutical composition comprising metformin and rosuvastatin

Also Published As

Publication number Publication date
MX343138B (en) 2016-10-25
WO2013019156A1 (en) 2013-02-07
EA201490380A1 (en) 2014-06-30
EP2736505A4 (en) 2014-12-24
EP2736505B1 (en) 2017-09-27
AU2012290734A1 (en) 2014-02-20
EA023954B1 (en) 2016-07-29
CN103841967A (en) 2014-06-04
JP2014523925A (en) 2014-09-18
KR20140060288A (en) 2014-05-19
EP2736505A1 (en) 2014-06-04
IL230694A0 (en) 2014-03-31
ZA201400695B (en) 2015-10-28
MX2014001225A (en) 2014-09-22
US20140296567A1 (en) 2014-10-02
CA2843401A1 (en) 2013-02-07

Similar Documents

Publication Publication Date Title
RS54207B1 (en) Condensed imidazolylimidazoles as antiviral compounds
MY182428A (en) Crystalline forms of a prolyl hydroxylase inhibitor
RS54386B1 (en) Antiviral compounds
BR112015028870A2 (en) hydroentangled fibrous structures
IN2015DN02573A (en)
PH12014501453A1 (en) Method of reducing exercise-induced joint pain in non-arthritic mammals
BR112015016608A2 (en) al cast alloy
BR112015029254A2 (en) low ph detergent composition comprising nonionic surfactants
DK3000808T3 (en) 5 - ((HALOPHENYL) -3-HYDROXY-PYRIDIN-2-YL) CARBOXYLIC ACID DERIVATIVES AS INTERMEDIATES FOR THE PREPARATION OF CARBONYLAMINO ALKANIC ACIDS, ESTERS AND AMIDES THEREOF
CR20130001A (en) DERIVATIVES OF INDOLIZINE, ITS PREPARATION PROCEDURE AND ITS APPLICATION IN THERAPEUTICS
MY165754A (en) Catalyst for producing acrylic acids and acrylates
ECSP15043422A (en) A PROCEDURE TO INCREASE THE FORMATION OF PYROGLUTAMIC ACID FROM A PROTEIN
MY178150A (en) Novel benzoic acid amide compound
HK1206938A1 (en) Process for the preparation of 3-chloro-4,5,6-trifluoro- picolinonitrile 3--456--
GT201300064A (en) AZA-ADAMANTAN DERIVATIVES MONOHIDRATE
IN2014CN00747A (en)
IT1400634B1 (en) PROCEDURE FOR THE PRODUCTION OF MUSHROOM COMPONENTS IN SPIRIOUS CAST IRON AUSTEMPERATA PARTICULARLY RESISTANT TO WEAR.
ECSP12011647A (en) PROCESS FOR THE PREPARATION OF AMIDAS OF CARBOXYL PIRAZOL ACID.
WO2015063795A3 (en) Novel process for preparation of optically pure norephedrine and its derivatives
CR20110208A (en) PROCESS FOR THE PREPARATION OF BENZONORBORNENOS
MX2012010443A (en) Process for the preparation of 5-substituted 1-alkyltetrazoles.
MX337612B (en) Oligosaccharides composition for preventing or reducing the risk of metabolic syndrome.
MX2015016283A (en) Methods for treatment of inflammatory conditions using s-[4-(3-fluoro-3-methylbutyryloxy) but-2-ynyl] 6alpha, 9alpha-difluoro-17alpha-(furan-2-yl) carbonyloxy-11beta -hydroxy-16alpha-methyl-3-oxoandrosta-1,4-diene-17beta -carbothioate.
BR112015000942A2 (en) use of vegfr-3 inhibitors to treat hepatocellular carcinoma
UY35108A (en) NEW SYNTHESIS PROCEDURE OF (2E) -3- (3,4-DIMETOXIFENIL) PROP-2-ENONITRILE, AND APPLICATION TO THE SYNTHESIS OF IVABRADINE AND ITS ADDITION SALTS TO A PHARMACEUTICALLY ACCEPTABLE ACID